PHARMA RESEARCH BIO Co., Ltd. (XKON:A217950) announced a private placement of series 2 registered convertible bonds of gross proceeds KRW 1,000,000,000 on June 28, 2017. The transaction includes participations from DTNI-KVIC Pangyo Creative Economy Valley Fund for KRW 1,000,000,000, a fund managed by Dt& Investment Co.,Ltd. The maturity date of the bonds is June 29, 2023. The issuance of bonds pursuant to the transaction is zero-coupon. The yield to maturity is 7%. The conversion rate is 100% and conversion price is KRW 20,500. Number of shares pursuant to the conversion is 48,780. The conversion period is from June 30, 2018 to June 28, 2023. The subscription date is June 28, 2017. The payment date for the transaction is June 29, 2017. This transaction has been approved by board of directors on June 28, 2017.